How Uterine Fibroids Develop and Grow: Why Size and Location Decide the Care Plan

She had gone in for a routine cervical screening and left with a word she had to look up in the parking lot. Fibroid. The clinician had said it lightly, almost in passing, and then added the part that lodged in her mind: “We’ll keep an eye on it.” Keep an eye on what, exactly? Something the size of a walnut, sitting in the wall of her uterus, quietly deciding whether to grow.

That uncertainty is the real story of fibroids. Most people who have them never know it. Others live with heavy periods for years before anyone connects the dots. Understanding how fibroids grow, what fuels them, and why a two-centimeter growth in one spot can cause more trouble than a ten-centimeter growth in another, is what turns a vague “we’ll watch it” into a plan you can actually follow.

This explainer walks through the biology, the growth patterns across life stages, and the reasons size and location, more than anything else, decide what your care team is likely to recommend.

How fibroids grow: a hormone-sensitive knot of muscle

A fibroid, known medically as a leiomyoma, is a benign tumor made of smooth muscle cells and fibrous connective tissue that arises from the muscular wall of the uterus, called the myometrium. Benign here means it does not spread to other organs. Mayo Clinic notes that fibroids are almost never cancerous and do not raise the risk of other uterine cancers.

Each fibroid appears to begin from a single muscle cell that acquires a genetic change and starts dividing when its neighbors do not. Over months and years those daughter cells pile up into a dense, rubbery, round mass with a whorled interior, surrounded by a thin rim that separates it from normal muscle. That rim is what surgeons follow when they shell a fibroid out during a myomectomy.

What keeps the mass enlarging is hormonal. Fibroid tissue carries more receptors for estrogen and progesterone than the surrounding uterus, so it responds more strongly to the same monthly hormone surges every other cell is exposed to. Estrogen encourages cells to multiply; progesterone appears to protect them from the normal process of dying off and drives production of the collagen-rich matrix that makes fibroids firm. Growth factors and local blood supply add to the effect, which is why some fibroids develop a visible network of feeding vessels.

This dependence on ovarian hormones explains the arc of a fibroid’s life. It is rare before puberty, most often found between the ages of 30 and 50 according to the NHS, and it usually stalls or shrinks once menopause switches the hormone supply off. It also explains why medicines that block or lower these hormones can temporarily reduce fibroid volume, and why that effect wears off when the medicine stops.

What triggers fibroids to grow? Risk factors and known drivers

Nobody has identified a single trigger, but several factors reliably shift the odds. Age is the strongest: the NHS estimates that around 1 in 3 women develop fibroids at some point, most often during the reproductive decades. Cleveland Clinic puts the lifetime figure even higher, at roughly 40% to 80% of people with a uterus, depending on how carefully imaging looks for small ones.

Ancestry matters. Mayo Clinic reports that Black women are more likely to develop fibroids, tend to develop them at a younger age, and more often have larger or more numerous fibroids with heavier symptoms. The reasons are still being studied and likely involve a mix of genetics, vitamin D status and environmental factors rather than any single cause.

Family history counts too. Having a mother or sister with fibroids raises the likelihood, which fits with the genetic changes found inside fibroid cells. Body weight is associated with risk, partly because fat tissue converts other hormones into estrogen, adding to the hormonal fuel supply. Mayo Clinic also lists early onset of menstruation, vitamin D deficiency, and a diet higher in red meat and lower in green vegetables and fruit among the factors linked to higher risk, while pregnancy appears to be associated with lower risk.

Two clarifications help here. First, association is not cause: none of these factors guarantees a fibroid will form or enlarge. Second, no everyday food, supplement or stress event has been shown to make a fibroid grow suddenly. Growth is a slow, hormone-paced process. When a fibroid does seem to enlarge quickly, the usual explanation is a change in blood supply or a pocket of fluid or bleeding inside it, not something the person did.

Where a fibroid sits changes everything: the four locations

Clinicians describe fibroids by their position relative to the layers of the uterus, and this vocabulary is worth learning because it predicts symptoms better than size alone.

• Intramural fibroids grow within the thickness of the muscular wall. They are the most common type and, when large, can stretch the uterus and cause heavier periods or pelvic pressure.
• Submucosal fibroids sit just beneath the endometrium, the inner lining that is shed each month, and bulge into the uterine cavity. Even small ones can cause heavy or prolonged bleeding and are the type most closely linked to fertility difficulties.
• Subserosal fibroids grow outward from the outer surface of the uterus toward the pelvis. They tend to spare periods but press on neighboring organs, producing urinary frequency, constipation or a feeling of fullness.
• Pedunculated fibroids hang from the uterus on a stalk, either into the cavity or out into the pelvis. The stalk can twist, cutting off blood supply and causing sudden pain.

Many people have more than one type at once. A uterus with several fibroids is sometimes described as “fibroid uterus,” and the overall size may be recorded the way pregnancy is, in weeks, because the enlarged uterus can be felt on examination at the same height a pregnant uterus would reach.

Location also shapes the route a procedure can take. A fibroid inside the cavity can often be reached through the cervix with a thin telescope, while one on the outer surface requires keyhole or open surgery to remove. This is the first reason your care team will spend as much time describing where a fibroid is as how big it is.

Why size and location decide the care plan: a fibroid size chart in context

Fibroid size is measured in centimeters on ultrasound or MRI. Mayo Clinic describes a range from seedlings invisible to the naked eye to bulky masses that can distort and enlarge the uterus. Everyday comparisons help: a pea, a walnut, a lime, a grapefruit. The number alone, though, tells only half the story. The table below pairs typical size bands with location to show why two fibroids of identical diameter can lead to very different conversations.

Size band	Submucosal (inside cavity)	Intramural (in wall)	Subserosal or pedunculated (outer surface)
Small (under about 2 cm)	Can still cause heavy bleeding; often removable through the cervix	Usually silent; commonly monitored	Usually silent; commonly monitored
Medium (about 2–6 cm)	Bleeding and fertility effects likely; hysteroscopic or other removal discussed	Heavier periods, pressure; medicines, embolization or myomectomy discussed	Pressure symptoms possible; monitoring or keyhole removal discussed
Large (above about 6 cm)	Rare in this position	Bulk symptoms, anemia risk; procedures more often discussed	Bladder or bowel pressure; surgery more often discussed

These bands are a teaching aid, not a rule book. Guideline pathways focus on symptoms, fertility wishes, the number of fibroids, and how close a fibroid sits to the cavity, then use size to narrow which procedures are technically suitable. A person with a large but silent subserosal fibroid may reasonably be monitored for years; a person with a small submucosal fibroid and iron-deficiency anemia may be offered treatment promptly. The care plan follows the problem the fibroid is actually causing, and that is decided by geography as much as by measurement.

What are the signs a fibroid is growing?

Most growth is silent. The NHS notes that only around 1 in 3 people with fibroids ever develop symptoms, so a fibroid can enlarge for years without announcing itself. When signs do appear, they tend to reflect either bleeding or bulk.

Bleeding changes come first for many. Periods that were manageable become heavier, longer, or arrive with clots. Bleeding between periods can occur, especially with submucosal fibroids. Over time, this quietly drains iron stores, so fatigue, breathlessness on stairs or pallor may be the first thing a person notices rather than the bleeding itself.

Bulk symptoms arrive as a fibroid takes up room. A sense of pelvic heaviness, a lower abdomen that feels firmer or looks fuller, needing to pass urine more often because the bladder has less space, constipation from pressure on the rectum, low back pain, or discomfort during sex are all described by Mayo Clinic and MedlinePlus as common fibroid symptoms. Some people simply notice that trousers fit differently.

Doctors track growth objectively rather than by symptoms alone. A pelvic examination can detect an enlarged or irregular uterus. Transvaginal or abdominal ultrasound measures each fibroid in three dimensions and maps its position. MRI is used when the picture is complex, when a procedure is being planned, or when the number and location of fibroids need to be mapped precisely. Repeat scans, typically months apart, show whether a fibroid is stable, shrinking or enlarging. Mayo Clinic points out that fibroids can grow slowly, grow quickly, stay the same, go through spurts, or shrink on their own, so a single measurement rarely settles the question. Trend over time is what matters.

At what age does a fibroid stop growing?

Fibroids tend to follow the hormone calendar. They are uncommon before puberty, appear and enlarge through the twenties, thirties and forties, and usually stop growing once menopause arrives. The NHS notes that fibroids often shrink after menopause because estrogen levels fall, and that symptoms usually ease or disappear at that point. In the United Kingdom, menopause most often occurs between 45 and 55, with an average around 51, according to NHS guidance; timing varies widely between individuals.

The years immediately before menopause, known as perimenopause, can be confusing. Hormone levels swing rather than decline smoothly, and cycles may become irregular and heavy for reasons unrelated to fibroids. A fibroid that has been quiet for a decade can seem to flare in this window simply because bleeding patterns are shifting. Equally, some people find their fibroid symptoms improve during perimenopause as estrogen exposure becomes more erratic.

Menopausal hormone therapy, sometimes called HRT, adds a wrinkle. Because it restores some estrogen and progesterone, it can maintain fibroid size or, less commonly, allow modest growth in someone who would otherwise have seen shrinkage. This does not mean hormone therapy is off limits for people with fibroids; it means the prescribing clinician weighs the benefit against fibroid history and may monitor more closely.

Growth after menopause without hormone therapy is unusual and is one of the situations that prompts further evaluation. Mayo Clinic advises that any vaginal bleeding after menopause, or a uterus that enlarges after periods have stopped, should be assessed rather than assumed to be an old fibroid behaving badly.

How fibroids change during pregnancy

Pregnancy floods the body with the very hormones fibroids respond to, so it is reasonable to expect every fibroid to balloon. The reality is more mixed. Mayo Clinic and MedlinePlus describe fibroids in pregnancy as commonly stable, with some enlarging, particularly in the first trimester, and others staying unchanged or even appearing smaller on later scans. Growth, when it happens, tends to be modest, and many fibroids return toward their pre-pregnancy size in the months after delivery.

The more distinctive pregnancy event is degeneration. As the uterus stretches, a fibroid can outgrow its blood supply. The tissue inside becomes starved, swells, and can bleed into itself, an event known as red degeneration. It causes localized, sometimes severe pain over the fibroid, occasionally with a low fever, usually in mid-pregnancy. The pain typically settles over days with rest and pain management directed by the obstetric team, and it does not mean the fibroid is dangerous. It does need to be assessed, because the symptoms can mimic other problems.

Whether a fibroid affects the pregnancy itself depends, once again, on location and size. Most fibroids cause no complications. Larger fibroids or those low in the uterus can, in some cases, be associated with breech position, a higher chance of cesarean birth, or heavier bleeding after delivery. Submucosal fibroids are the type most associated with difficulty conceiving and with early pregnancy loss, because they distort the cavity where an embryo implants.

Surgery to remove fibroids is generally avoided during pregnancy because of bleeding risk. Planning happens beforehand for people who know they have fibroids and are trying to conceive, and afterwards if problems arose. The obstetric team monitors the fibroid with routine scans and adjusts the birth plan if needed.

What makes fibroids go away?

Three things reliably reduce a fibroid: loss of hormonal fuel, loss of blood supply, or physical removal. Nothing on the supplement shelf has been shown to do any of these.

Menopause is the natural version of the first route. Once ovarian estrogen and progesterone fall, fibroids typically shrink and soften, though they rarely vanish entirely; a shrunken, sometimes calcified remnant may remain visible on scans for life. Medicines that temporarily lower hormone levels, such as GnRH agonists and antagonists (described in a later section), mimic this effect but only while they are taken.

Cutting off blood supply is the second route. Uterine artery embolization, a procedure in which tiny particles are injected into the arteries feeding the fibroids, causes them to shrink over subsequent months. Spontaneous degeneration, when a fibroid outgrows its own vessels, is nature’s less orderly version of the same principle.

Physical removal is the third route: myomectomy removes the fibroids and leaves the uterus; hysterectomy removes the uterus and with it any current or future fibroids.

What does not make fibroids disappear is worth stating plainly, because the internet is full of claims. Diet changes, herbal blends, castor oil packs, detox programs and specific exercise regimes have not been shown in reliable studies to shrink fibroids. A healthy diet and weight are sensible for many reasons and may modestly influence risk over years, but they are not treatments for an existing fibroid. Vitamin D deficiency is associated with higher fibroid risk, and correcting a deficiency is reasonable for general health, but the evidence that supplementation shrinks established fibroids is preliminary and not something guidelines rely on. Anyone considering a supplement should discuss it with their care team.

Who is usually offered treatment, and who is usually asked to wait

The single most important question in fibroid care is not “how big is it?” but “what is it doing to you?” Guideline pathways from bodies such as NICE and the guidance summarized by the NHS start from symptoms, then layer in fertility plans, fibroid position, overall health and personal preference.

People commonly asked to wait, meaning monitor with periodic check-ins and scans, include those whose fibroids were found incidentally and cause no symptoms, those with mild symptoms they find manageable, and those approaching menopause whose fibroids are likely to shrink on their own within a few years. The NHS notes that fibroids without symptoms often need no treatment at all. Watchful waiting is an active choice, not neglect; it involves knowing which changes should prompt a return visit.

Treatment is more often discussed when bleeding is heavy enough to cause anemia or disrupt daily life, when pressure symptoms affect the bladder, bowel or comfort, when pain is recurrent, when a fibroid distorts the uterine cavity in someone trying to conceive, or when a fibroid is growing steadily on serial scans. Within that group, the ladder usually begins with the least invasive option that fits the problem: medicines for bleeding, then procedures matched to location, then surgery.

Fertility wishes shift the ladder. Someone planning pregnancy will generally be steered toward options that preserve the uterus and, where possible, its cavity. Someone who has completed their family and has multiple large fibroids may be offered a wider range including hysterectomy. Age, other medical conditions, prior surgery and how much recovery time a person can accommodate all feed in.

None of this happens on autopilot. The treating team weighs the evidence for each option against the individual in front of them, and the final decision rests with that team and the patient together.

How medicines slow fibroid growth or manage bleeding

Medicines for fibroids work in one of two ways: they reduce bleeding without changing the fibroid, or they lower hormone levels so the fibroid shrinks temporarily. Knowing which category a medicine belongs to helps set expectations. Any decision to start, continue or stop one of these sits with the prescribing clinician.

Bleeding-focused options. Tranexamic acid helps blood clot at the level of the uterine lining and is taken only during periods. Anti-inflammatory painkillers of the NSAID class reduce both pain and, modestly, blood loss. Hormonal contraceptives, including the combined pill and the levonorgestrel-releasing intrauterine system, thin the lining so periods become lighter. The NHS describes these as first-line approaches for heavy bleeding caused by fibroids. They do not shrink the fibroid, and the NHS notes the intrauterine system may not be suitable when fibroids distort the cavity.

Hormone-lowering options. GnRH agonists and the newer oral GnRH antagonists act on the brain’s control of the ovaries, dropping estrogen and progesterone to menopausal levels. Fibroids typically shrink over the following weeks to months, and bleeding usually stops. The trade-off is menopausal symptoms and, with longer use, loss of bone density, which is why the NHS describes GnRH agonists as short-term treatment, generally for a maximum of six months, often to shrink fibroids before surgery. Some regimens combine these with low-dose hormone “add-back” to protect bone, extending how long they can be used. When the medicine stops, hormones return and fibroids usually regrow toward their previous size.

Mayo Clinic summarizes the principle well: medicines target hormones and symptoms rather than eliminating fibroids. For many people that is exactly what is needed, especially close to menopause or while planning the timing of a procedure.

Procedures explained: from hysteroscopy to hysterectomy

When medicines are not enough or not suitable, procedures are matched to fibroid location, number and size, and to whether the person wishes to keep the uterus or the option of pregnancy.

Hysteroscopic myomectomy removes submucosal fibroids through the cervix using a thin telescope and a cutting instrument, with no abdominal incision. It suits fibroids that sit mostly inside the cavity and are small enough to be shaved away safely.

Endometrial ablation destroys the lining of the uterus to reduce bleeding. It does not remove fibroids and is not suitable for people who want to become pregnant. The NHS lists it as an option for heavy bleeding when fibroids are small.

Uterine artery embolization is performed by an interventional radiologist through a small puncture in the groin or wrist. Particles block the arteries feeding the fibroids, which then shrink over months. The uterus is preserved; the effect on future fertility is less certain, which is why it is discussed carefully with people who plan pregnancy.

MRI-guided focused ultrasound heats and destroys fibroid tissue through the skin using focused sound waves, guided by MRI. It suits selected fibroids and is not available everywhere.

Laparoscopic or open myomectomy removes intramural and subserosal fibroids through keyhole incisions or a larger abdominal cut, keeping the uterus. It is the usual choice for people who want to preserve fertility and have fibroids that cannot be reached through the cervix. New fibroids can form afterwards.

Hysterectomy removes the uterus and is the only approach after which fibroids cannot return. It ends menstruation and the possibility of pregnancy. Ovaries are often left in place so hormones continue.

Each option carries its own risks, including bleeding, infection, injury to nearby organs and anesthetic complications, and each has situations where it is not advised. The treating team lays these out in relation to the person’s specific fibroids.

What the days and weeks after treatment usually look like

Recovery depends almost entirely on which route was taken, and the ranges below are typical patterns described in NHS guidance rather than promises for any individual.

After hysteroscopic procedures, most people go home the same day. Cramping and light bleeding for a few days are common, and normal activity often resumes within a day or two. The first period afterwards may be different from usual while the lining heals.

After uterine artery embolization, the NHS describes an overnight stay in some cases and a period of cramping pain in the first days as the fibroids lose their blood supply; pain management is planned in advance. Fatigue and low-grade fever can occur in the first week. Most people return to usual activities within a couple of weeks, but the fibroids themselves shrink gradually over several months, so the improvement in pressure symptoms lags behind the improvement in bleeding.

After laparoscopic myomectomy, hospital stays are usually short and people are often back to light activity within two to four weeks, longer for strenuous work. Open myomectomy and abdominal hysterectomy involve a larger incision; NHS guidance on hysterectomy describes recovery typically taking around 6–8 weeks, with lifting and driving restricted until the wound and core have healed and the person can perform an emergency stop comfortably.

Across all routes, two threads run through the early weeks. The first is movement: walking early and often reduces the risk of blood clots, which is why teams encourage getting up soon after surgery and may provide compression stockings or blood-thinning injections in hospital. The second is watching for the red-flag signs in the final section. Follow-up is usually arranged before discharge, and scans to confirm fibroid shrinkage after embolization or focused ultrasound are typically scheduled months later, when the change has had time to show.

Do fibroids shrink after menopause, and other things people often get wrong

“Fibroids always turn into cancer if they grow fast.” They do not. Mayo Clinic is explicit that fibroids are almost never cancerous. A rare, separate cancer of uterine muscle called leiomyosarcoma exists, and rapid growth after menopause or unusual imaging features prompt evaluation, but rapid growth in a premenopausal person is far more often due to bleeding or fluid inside a benign fibroid.

“They will definitely shrink at menopause, so I can ignore symptoms.” Most do shrink, as the NHS describes, but menopause can be a decade away, and untreated heavy bleeding can cause years of anemia in the meantime. Timing matters when weighing whether to wait.

“A bigger fibroid is always worse.” A small submucosal fibroid can cause more bleeding than a large subserosal one. Location, not size, usually determines the symptom.

“Fibroids mean I cannot have children.” Most people with fibroids conceive and carry pregnancies without difficulty. Fertility effects are concentrated in fibroids that distort the cavity, and those can often be treated.

“Removing fibroids removes the problem for good.” After myomectomy, new fibroids can form because the underlying tendency remains. Only hysterectomy prevents recurrence.

“Diet or herbs dissolved my fibroid.” Fibroids fluctuate and sometimes shrink on their own, as Mayo Clinic notes; a coincidence in timing is not evidence. No dietary approach has been shown to shrink established fibroids.

“Hysterectomy is the only real option.” For many people it is one of several, and uterus-preserving procedures are widely used. For others, after full discussion, it is the right choice. Neither view should be assumed before the conversation happens.

Questions to ask your care team about how fibroids grow and what to do

Consultations move quickly, and the most useful questions are the ones that connect the scan report to your own life. Consider bringing a short list such as the following and asking for answers in plain language.

• Where exactly are my fibroids, how many are there, and which ones are likely responsible for my symptoms?
• How large is each one now, and do we have an earlier measurement to compare against?
• Are any of them inside or distorting the uterine cavity, and does that matter for my plans?
• Would you recommend monitoring, and if so, how often should I be scanned and what changes should bring me back sooner?
• Have my iron levels been checked, and if I am anemic, how will that be managed alongside the fibroids?
• Which options fit my fibroids specifically, and which are ruled out by their size or location?
• For each option, what are the main risks, what does recovery involve, and what happens if it does not work?
• How would each option affect my chance of pregnancy or a future pregnancy?
• If I am approaching menopause, how does that change the balance between waiting and treating?
• Could a short course of hormone-lowering medicine before surgery make the operation simpler or safer in my case?
• Will treatment now reduce or increase the chance of needing another procedure later?
• Who do I contact if symptoms change between appointments?

It is reasonable to ask for a copy of your imaging report and to request time to think before committing to a procedure. Writing down the answers, or bringing someone to listen, helps when the decision is complex. The care team is there to lay out the evidence and the trade-offs; the decision is made together, at a pace that suits you.

When to call your doctor

Most fibroid symptoms unfold slowly and can be discussed at a scheduled appointment. Some situations should not wait.

Seek urgent care the same day, or emergency care if severe, for:

• Sudden, severe pelvic or abdominal pain, especially with nausea or fever, which can signal a twisted pedunculated fibroid or acute degeneration.
• Bleeding heavy enough to soak through a pad or tampon every hour for several hours, or passing large clots repeatedly.
• Dizziness, fainting, a racing heart, chest pain or breathlessness, which may indicate significant blood loss or anemia.
• Inability to pass urine, or severe constipation with abdominal swelling and vomiting.
• Any vaginal bleeding after menopause, as Mayo Clinic advises, since this always needs assessment.
• Severe pain, heavy bleeding or fever during pregnancy.

After a procedure, contact the treating team promptly for:

• Fever, chills, or wound redness, warmth or discharge.
• Pain that worsens rather than eases after the first days, or pain not controlled by the plan given at discharge.
• Heavy or foul-smelling vaginal discharge.
• Calf pain or swelling, chest pain, or sudden shortness of breath, which can indicate a blood clot.

Book a routine appointment for: periods becoming steadily heavier or longer, new pressure on the bladder or bowel, a fuller or firmer lower abdomen, new pain during sex, difficulty conceiving after a year of trying, or persistent tiredness. These are the changes that suggest a fibroid is growing or affecting daily life, and they are best assessed with an examination, blood tests and imaging rather than waited out. Your treating team can then decide, with you, whether the plan should change.

Frequently asked questions

What triggers fibroids to grow?

Estrogen and progesterone are the main drivers; fibroid cells respond more strongly to these hormones than normal uterine muscle. Age during the reproductive years, family history, Black ancestry, higher body weight, early first periods and vitamin D deficiency are associated with higher risk, according to Mayo Clinic. No specific food, stress event or supplement has been shown to trigger sudden growth. Apparent rapid enlargement is usually bleeding or fluid inside a benign fibroid.

At what age does a fibroid stop growing?

Fibroids usually stop growing at menopause, when ovarian estrogen and progesterone fall, and the NHS notes they often shrink afterwards. Menopause most commonly occurs between 45 and 55. Hormone replacement therapy can maintain fibroid size in some people, so clinicians may monitor more closely. Growth or bleeding after menopause without hormone therapy is unusual and should always be assessed rather than attributed to an old fibroid.

What makes fibroids go away?

Fibroids shrink when they lose their hormonal fuel, lose their blood supply, or are physically removed. Menopause does the first naturally; GnRH-type medicines do it temporarily; uterine artery embolization blocks blood flow; myomectomy or hysterectomy removes them. Diets, herbs and detox regimens have not been shown to shrink established fibroids. Fibroids sometimes shrink spontaneously, as Mayo Clinic notes, which can make unproven remedies look effective by coincidence.

What are the signs a fibroid is growing?

Heavier or longer periods, bleeding between periods, pelvic heaviness, a fuller lower abdomen, needing to urinate more often, constipation, low back pain or discomfort during sex can all suggest growth. Fatigue from iron deficiency is sometimes the first clue. Because many fibroids grow without symptoms, doctors confirm change with repeat ultrasound or MRI measurements taken months apart rather than relying on symptoms alone.

Is there a fibroid size chart doctors use to decide treatment?

Clinicians measure fibroids in centimeters and loosely group them as small, medium or large, but no size cut-off alone decides treatment. Guideline pathways start from symptoms, fertility plans and location, then use size to work out which procedures are technically suitable. A small fibroid inside the cavity may be treated sooner than a large silent one on the outer wall. Size bands are a teaching aid, not a rule.

Do fibroids shrink after menopause?

Most do. The NHS explains that falling estrogen after menopause usually causes fibroids to shrink and symptoms to ease or disappear. They rarely vanish completely; a smaller, sometimes calcified remnant can remain visible on scans. Menopausal hormone therapy may slow this shrinkage in some people. Any new bleeding or enlargement after menopause needs assessment rather than being assumed to be fibroid-related.

Can fibroids grow during pregnancy?

Some do, particularly in the first trimester, but Mayo Clinic and MedlinePlus describe most as stable or only modestly changed, and many return toward their earlier size after delivery. The more distinctive event is degeneration, when a fibroid outgrows its blood supply and causes localized pain, usually mid-pregnancy. Most fibroids do not affect the pregnancy; larger or low-lying ones are monitored because they can influence baby position or delivery planning.

How fast do fibroids grow?

Growth is highly variable and unpredictable. Mayo Clinic notes fibroids can grow slowly or quickly, stay the same, go through growth spurts, or shrink on their own, sometimes within the same person. Because of this, a single scan cannot forecast the future; repeat measurements months apart show the real trend. Rapid growth in someone still having periods is usually benign, while growth after menopause prompts further evaluation.

Can a fibroid come back after it is removed?

Yes, after myomectomy. The procedure removes existing fibroids but the underlying tendency to form them remains, so new fibroids can develop over the following years, particularly in younger people with many fibroids. Uterine artery embolization and focused ultrasound treat existing fibroids and new ones can also form. Hysterectomy is the only approach after which fibroids cannot recur, because the uterus is removed.

Are growing fibroids ever cancer?

Almost never. Mayo Clinic states that fibroids are almost never cancerous and do not increase the risk of other uterine cancers. A rare separate cancer of uterine muscle, leiomyosarcoma, does exist, and clinicians evaluate rapid growth after menopause, unusual imaging features or postmenopausal bleeding to rule it out. In someone still menstruating, apparent fast growth is far more often bleeding or fluid inside a benign fibroid.

References

• NHS: Fibroids
• Cleveland Clinic: Uterine fibroids
• MedlinePlus: Uterine fibroids
• NHS: Hysterectomy, recovery

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.